NASDAQ:XERS

Xeris Pharmaceuticals Stock Predictions

etoro logo Buy XERS
*Your capital is at risk
$5.89
-0.110 (-1.83%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

XERS Prediction Chart

XERS Predictions History

Latest community submissions for XERS.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 2, 2025 $5.20 +2.36% $5.15 V 99.03% 2
Apr 2, 2025 $5.16 +1.48% $5.15 V 99.90% 10
Skagitqg Skagitqg Merchant
Apr 2, 2025 Bearish $5.15 V 0
Apr 1, 2025 $5.60 +2.05% $5.08 X 89.71% 0
Apr 1, 2025 $5.56 +1.28% $5.08 X 90.54% 0
Apr 1, 2025 Bullish $5.08 X 0
Mar 18, 2025 $4.92 -2.10% $5.22 X 94.34% 0
Mar 18, 2025 $4.96 -1.31% $5.22 X 95.10% 0
Skagitqg Skagitqg Merchant
Mar 18, 2025 Bullish $5.22 V 1
Mar 7, 2025 $4.04 -2.11% $4.24 X 95.35% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for XERS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT XERIS PHARMACEUTICALS INC
Xeris Pharmaceuticals
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE